Semantic Scholar uses AI to extract papers important to this topic.
Thiazolidinediones are insulin-sensitizing agents and in clinical use for the treatment of type II diabetes. Under specific… Expand The present study examined the roles of peroxisome proliferator-activated receptors (PPAR) in activation of hepatic stellate… Expand Bone morphogenetic proteins (BMPs) were discovered as potent bone‐inducing molecules. Their effect on adipogenic differentiation… Expand Peroxisome proliferator-activated receptor γ (PPARγ) is a nuclear receptor that functions as a transcription factor to mediate… Expand The peroxisome proliferator-activated receptor-γ (PPAR-γ) is a ligand-dependent transcription factor that is important in… Expand Thiazolidinediones (TZDs) constitute an exciting new class of antidiabetic compounds, which function as activating ligands for… Expand Activation of peroxisome proliferator-activated receptor (PPAR) gamma, a nuclear receptor highly expressed in adipocytes, induces… Expand Intracellular fatty acid (FA) concentrations are in part determined by a regulated import/export system that is controlled by two… Expand The thiazolidinediones improve insulin sensitivity in animal models and have promise as potent oral antidiabetic agents. Their… Expand Thiazolidinedione derivatives are antidiabetic agents that increase the insulin sensitivity of target tissues in animal models of… Expand